Elliot Norry, the Chief Medical Officer of $ADAP ($ADAP), sold 5,584 shares of the company on 01-17-2025 for an estimated $3,243. We received data on the trade from a ...
Commercial: Is the 340B Drug Pricing Program the Next 'Too Big to Fail'? Macsata noted the recent patient perspectives survey on medical debt, commissioned by ADAP Advocacy, which found that nearly ...
Commercial: Is the 340B Drug Pricing Program the Next 'Too Big to Fail'? WASHINGTON, May 15, 2025 /PRNewswire/ -- ADAP Advocacy today, as part of its 340B Project, aired a new commercial calling for ...
ADAPTIMMUNE THERAPEUTICS ($ADAP) posted quarterly earnings results on Tuesday, May 13th. The company reported earnings of -$0.18 per share, missing estimates of -$0. ...